Founder of ChiroHer, Oklahoma City's dedicated women's chiropractic clinic
It operates by mimicking the natural action of HGH on fat metabolism but without the muscle growth, water retention, or potential side effects associated with HGH use
GLP-1 agonists are FDA-approved medications with extensive clinical data, while 5-amino-1MQ remains a research compound
Research demonstrates reductions in adipocyte size of 30-40%, with preferential targeting of visceral fat, the most metabolically harmful fat type
A 2018 study found 5-amino-1MQ increased NAD+ by up to 40% in cultured adipocytes, but this cellular change precedes noticeable effects by weeks
Variables such as body weight, calorie intake, energy expenditure, glucose, and fat oxidation, insulin, and glycerol were measured before and after treatment with AOD9604 and hGH